Related to mTNBC and indirectly NGIO as well as Re
Post# of 36537
As of now the company is expecting to study 30 plus indications for the medicine, including inflammatory problem common in the bowel such as IBD and Crohn's.
I brought this company up a while back. Joe was at best lukewarm on the platform. Would have potentially been a great company to partner with considering the cancer and bowel synergies.